kinetic study on the reactions of platinum drugs with glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer A platinum(IV) prodrug strategy to
A platinum(IV) prodrug strategy to overcome glutathione based oxaliplatin resistance Communications Chemistry kinetic study on the reactions of platinum drugs with glutathione Schematic representation A: Mode of action of platinum based drug Recent Advances of PlatinumBased Anticancer The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs Chemical Reviews Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium Flavin Catalyst Organometallics
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




